There are a number of key elements to that. First and foremost is the leadership that we have with Dan and the Jaffee family. Dan is the third generation leader of our business, and because of that, we have very consistent strategy focus and our strong core values that we bring to this business. Oil-Dri also has, as I mentioned, a very diverse portfolio Amlan and the animal nutrition health business is a great addition to that. We leveraged the very strong vertical integration of Oil-Dri being able to control the product from the ground all the way to the customer, ensuring that we have quality and traceability and sustainability in our products. We use a single source mineral, a number of locations, but a single source mineral that brings tremendous technology to this space.
And Oil-Dri has been very consistent over the years in the investments we have on innovation, building out our innovation campus, and a strong team of R&D professionals that really allow us to create differentiating value for the marketplace. As we look at the type of products in portfolio that Amlan is developing, and where we focus in the market, it really is around four key areas that are reflected on the left, and then the illustration of the value opportunity, in the animal diet on the right side of this slide. As antibiotics and other pharmaceuticals are removed very rapidly now from animal diets, driven both by regulatory compliance requirements, as well as strong consumer preferences, there’s a tremendous opportunity for Oil-Dri, Amlan to develop products that can meet the need as these products, pharmaceutical products are removed from diets; these help support animal growth and productivity and improve the efficiency of animal production.
The pharmaceutical products that are being removed also help prevent disease in animals and allow producers, veterinarians, nutritionists to have high productivity and reduce the challenges of disease in their operations. Oil-Dri has a whole host of natural products that can help support an animal’s natural immune system, support the natural development of the microbial ecology in the gut of the animal, and really improve the performance as an animal digests and utilizes nutrients for growth and reproduction. So again, Oil-Dri, Amlan has a tremendous opportunity to target this segment. The other areas that we focus on are a little harder to quantify in terms of the absolute value, but we know that maintaining an optimal gut health and immunity in the animal really improves its utilization of nutrients and allows for optimal productivity and then, of course animal welfare and sustainability.
Healthy animals are animals that have a much more productive life. It allows us to produce animals in a much more sustainable way for food production. And it’s the absolute requirement now that consumers have that we are mindful of animal welfare and sustainability, and Amlan is a big part of helping the industry achieve that. Now I’m going to shift my focus to the North American market and talk to you a little bit about why we’re so excited about this region for growth for the Amlan business. As we look at the opportunity in North America, it really starts with our team there. We have a team of professionals with over a hundred years of collective experience in this industry. Team members that are well known by our customers and that have high credibility in this market.
Keith Vessels is the VP of Sales for the Americas for Amlan. So that includes not only North America, but also our Latin American business, where we also are going to see tremendous opportunities for growth in the future. Dr. Aldo Rossi was mentioned earlier, being promoted to VP of Innovation and Technical Service. Aldo also has long experience in this industry, well respected veterinarian, and will help us align and develop a world class technical service team, as well as manage our regulatory affairs and innovation activities for Amlan. Jay Hughes is our Director of Technical Service for the Americas. Jay also has a long history in the industry, working at both a primary breeding company as well as an agricultural statistics company. Jay is well known by our customers and will be optimizing our technical services programs for the Americas, helping customers utilize our products, and also helping to manage field issues that they may be experiencing in their operations.
And then Chuck Snipes, Chuck is our key Account Manager in North America, again well known in this industry, tremendous relationships across the various species that he’s covering. Chuck has been a great attribute to the team and is really helping to drive the growth that we’re seeing in North America. Now, why are we interested in North American market? Why is it a focal point for Amlan? This chart illustrates that on the left or Y-axis, you see the 2021 feed production in million metric tons. And on the bottom of this chart, in the X-axis, you see the compounded annual growth rates. The swine and broiler production is tremendous in the United States and beef also with a tremendous volume of feed that is required for this market. The North American region is the world’s largest broiler meat producer per capita.
And there’s a very high correlation, as you see in this chart between the poultry and the swine industries. The top 10 producers in North America dominate the market. This gives us a very focused access to the market and the opportunity to grow. These companies are large, global, vertically integrated cross species, food and feed companies, which again gives us the opportunity to grow not only in poultry, but also the other species that are important to us. The U.S. is the world’s largest producer of broiler meat, and of fresh milk. And we’re second in the production of pork meat and beef meat. So a tremendous opportunity in the North American market and why Amlan is focused here.
Sorbent: Then below sorbent, we have a range of formulated products that utilize our clay as its backbone, but also bring in other additional compounds or adjuvants that allow us to have a broad portfolio focusing on a range of opportunities. Again, as pharmaceuticals other drugs or chemicals are removed from the diet driven both by regulatory requirements as well as consumer demand for clean food and feed. So this is the portfolio we’re bringing to the United States, very excited about the opportunity that it offers, and we’re seeing good acceptance by our customers as we roll this out. Year-over-year, the Amlan global sales have increased approximately 18%, tremendously strong growth, again driven by growth in all world areas, but also our rollout of our U.S. products, our North American products that are starting to penetrate the market.
As feed prices rise in this state, we currently have a high commodity prices with the ban in Europe on meat being fed antibiotics. All of these are helping to drive the need for natural solutions that can provide the value that products previously utilized or once did. So we’re seeing growth that we believe will be sustained and rapid across North America. Our sales have doubled in this region as we launched our new branded portfolio, as I mentioned, and this in large part is due to the team that we have and the strong efficacy that customers are seeing as they test and begin to utilize our products. I do want to mention that Asia still remains important to our long-term growth. We expect our sales in China to stabilize in fiscal year 2023.
We saw a lot of challenges in the region from the pandemic, from supply chain, from the African swine flu. But all these are starting to stabilize, and we’re starting to see growth again in this region. The balance of Asia is expected to show significant growth in 2023 as demand rebounds. And really at the bottom line, the world’s demand for high quality protein will continue unabated. We have to be more efficient. We have to produce more and higher quality protein to meet the demands of the world, and Amlan is going to be a key part of that for the industry. So finally, looking ahead, North America is going to be a key element to our success. And within the America’s, North America is going to be a strong focus for us in the next coming years.
